Genes in panel
STRs in panel
Prev Next

Mitochondrial disorders

Gene: SPATA5

Amber List (moderate evidence)

SPATA5 (spermatogenesis associated 5)
EnsemblGeneIds (GRCh38): ENSG00000145375
EnsemblGeneIds (GRCh37): ENSG00000145375
OMIM: 613940, Gene2Phenotype
SPATA5 is in 7 panels

5 reviews

Arina Puzriakova (Genomics England Curator)

Comment on list classification: There are sufficient cases to promote this gene to Green at the next GMS panel update. Patients display a phenotype that resembles a mitochondrial disorder and functional studies on patient-derived cells have demonstrated an impact on mitochondrial function, further supporting inclusion of SPATA5 on this panel.
Created: 12 Mar 2024, 4:24 p.m. | Last Modified: 12 Mar 2024, 4:24 p.m.
Panel Version: 4.162

Achchuthan Shanmugasundram (Genomics England Curator)

Added new-gene-name tag, new approved HGNC gene symbol for SPATA5 is AFG2A.
Created: 16 Oct 2023, 6:19 p.m. | Last Modified: 16 Oct 2023, 6:19 p.m.
Panel Version: 4.99

Zornitza Stark (Australian Genomics)

Green List (high evidence)

At least five cases with biallelic variants had a clinical presentation resembling a mitochondrial disorder. Functional assays showed SPATA5-deficient neurons had a significant imbalance in the mitochondrial fusion-fission rate, impaired energy production and short axons.
Created: 23 Mar 2020, 3:44 a.m. | Last Modified: 23 Mar 2020, 3:44 a.m.
Panel Version: 2.5

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Epilepsy, hearing loss, and mental retardation syndrome MIM#616577

Publications

Variants in this GENE are reported as part of current diagnostic practice

Sarah Leigh (Genomics England Curator)

Comment on list classification: This gene is being rated as amber as it has not been reviewed as green by the GMS Mitochondrial specialist test group.
Created: 20 Aug 2019, 3:29 p.m. | Last Modified: 20 Aug 2019, 3:29 p.m.
Panel Version: 1.479

Rachel Jones (GSTT)

Green List (high evidence)

Greater than 15 families have been identified in multiple publications showing that patients with SPATA5 biallelic variants present with intellectual disability, epilepsy, microcephaly and hearing loss, as well as cortical blindness, spasticity and feeding problems; and prior to the gene being discovered to cause the phenotype in these families patients were often thought to have a mitochondrial disorder.

As per Puusepp et al (PMID: 29343804) functional studies were performed on rat cortical neurons. "SPATA5-deficient neurons had a significant imbalance in the mitochondrial fusion-fission rate, impaired energy production and short axons. In conclusion, SPATA5 protein has an important role in mitochondrial dynamics and axonal growth. Biallelic variants in the SPATA5 gene can affect mitochondria in cortical neurons and should be considered in patients with a neurodegenerative disorder and/or with clinical presentation resembling a mitochondrial disorder."
Sources: Literature
Created: 19 Aug 2019, 3:52 p.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Epilepsy, hearing loss, and mental retardation syndrome 616577

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
Phenotypes
  • Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities, OMIM:616577
Tags
new-gene-name Q1_24_promote_green
OMIM
613940
Clinvar variants
Variants in SPATA5
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

12 Mar 2024, Gel status: 2

Added Tag

Arina Puzriakova (Genomics England Curator)

Tag Q1_24_promote_green tag was added to gene: SPATA5.

12 Mar 2024, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: SPATA5 were set to 27246907; 29343804; 26299366; 28293831

12 Mar 2024, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: spata5 has been classified as Amber List (Moderate Evidence).

12 Mar 2024, Gel status: 2

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: SPATA5 were changed from Epilepsy, hearing loss, and mental retardation syndrome 616577 to Neurodevelopmental disorder with hearing loss, seizures, and brain abnormalities, OMIM:616577

2 Oct 2023, Gel status: 2

Added Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag new-gene-name tag was added to gene: SPATA5.

20 Aug 2019, Gel status: 2

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: SPATA5 were set to PMID: 27246907; 29343804; 26299366

20 Aug 2019, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: spata5 has been classified as Amber List (Moderate Evidence).

19 Aug 2019, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance

Rachel Jones (GSTT)

gene: SPATA5 was added gene: SPATA5 was added to Mitochondrial disorders. Sources: Literature Mode of inheritance for gene: SPATA5 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SPATA5 were set to PMID: 27246907; 29343804; 26299366 Phenotypes for gene: SPATA5 were set to Epilepsy, hearing loss, and mental retardation syndrome 616577 Penetrance for gene: SPATA5 were set to Complete Review for gene: SPATA5 was set to GREEN